Androgenetic alopecia

This study tests whether a special shampoo regimen can improve scalp health and reduce dandruff in 120 Chinese men who have had hair transplants. Some participants have mild-to-moderate seborrheic dermatitis (a common dandruff condition). The test group uses a special shampoo plu…

This pilot study tests a 1470nm laser on 10 adults with androgenetic alopecia (common baldness) or scarring alopecia. Researchers will measure hair density and counts using imaging, and track satisfaction. The goal is to see if the laser is safe and can improve hair growth.

This study tests a new treatment called EPI-001 for androgenetic alopecia (common baldness). EPI-001 is made from a patient's own scalp cells and injected into the scalp. The trial has two parts: first, finding the safest dose in a small group, then comparing the best dose to a p…

This study is testing a device called Ultra that uses low-level laser light to help hair grow back. It involves 44 adults aged 22 to 70 with male or female pattern baldness. Participants will receive six laser treatments on their scalp, two weeks apart, and researchers will check…

This early-stage trial tests whether ABS-201, an antibody that blocks a hormone receptor, is safe for treating hair loss. It starts with healthy volunteers and then includes people with male or female pattern baldness. Participants receive either the drug or a placebo and are mon…

This study compares a new peptide-based hair serum to the standard treatment minoxidil for people with pattern baldness. About 80 adults with mild to moderate hair loss will use one of the two treatments for 24 weeks. Researchers will measure changes in hair density and thickness…

This phase 3 trial tests whether a daily 1 mg minoxidil pill can treat female pattern hair loss as effectively as the standard topical minoxidil solution. About 520 women with hair thinning will be randomly assigned to receive either the oral pill, the topical solution, or a plac…

This study is testing whether combining platelet-rich plasma (PRP) with Botox injections works better than PRP alone for treating androgenetic alopecia (common pattern baldness). About 76 adults aged 18 to 60 with mild to moderate hair loss will receive either the combo treatment…

This study tests whether applying a probiotic (Lactobacillus reuteri) to the scalp daily for 12 months can safely increase hair density in people with androgenetic alopecia (male or female pattern baldness). About 388 adults aged 18-60 will be randomly assigned to receive the act…

This Phase 3 trial tests a new topical solution called TH07 for male pattern baldness. It combines three active ingredients (minoxidil, finasteride, and latanoprost) to see if it grows more hair than standard minoxidil or a placebo. 420 men aged 18-49 with moderate hair loss will…

This study tests an experimental drug called OLX72021 in 158 men with mild to moderate male pattern baldness. The drug is injected into the scalp at different doses to see if it is safe and can increase hair count compared to a placebo. The trial is currently recruiting participa…

This study tests if a once-daily 5% minoxidil foam can help women with androgenetic alopecia (female pattern hair loss) grow more hair. About 294 women aged 18 and older with mild to moderate hair loss will use either the foam or a placebo for 24 weeks. The main goal is to see if…

This study tests whether injections of secretome (a substance made by stem cells) or platelet-rich plasma (PRP) can improve hair density and thickness in people with androgenetic alopecia (common baldness). Forty men and women with mild to moderate hair loss will receive injectio…

This study tests a treatment called autologous hair follicle secretome (aHFS) for androgenic alopecia (common baldness). The treatment is made by taking hair follicles from the person, growing them in a lab, and collecting the substances they release. These are then injected into…

This study tests whether tiny particles from stem cells (exosomes) can safely help regrow hair in men with androgenic alopecia (male pattern baldness). The exosomes are delivered into the scalp using a microneedle device. The trial will enroll 18 men aged 18 to 60 with mild to mo…

This Phase 3 trial tests a new hair lotion called Finlândia for male pattern baldness. About 190 men aged 18-60 with moderate hair loss will use the lotion or a standard treatment for 6 months. The main goal is to see if it increases hair density on the scalp.

This study tests whether a treatment made from umbilical cord stem cell exosomes can help young men with male pattern baldness grow thicker, fuller hair. About 59 men aged 18-35 will receive either the exosome injections or standard minoxidil lotion. The goal is to see if the exo…

This study tests an oral drug called VDPHL01 in 552 women aged 18–65 with mild to moderate hereditary hair loss. Participants take a pill once or twice daily for about 13 months. The goal is to see if it increases hair count and if women feel their hair looks better. It's a place…

This study tests a new gel (2-Deoxy-D-ribose) against the standard hair loss treatment, minoxidil, in 60 adults aged 18 to 50 with mild to moderate hair loss. Participants will apply either the gel or minoxidil to their scalp daily for 6 months. The goal is to see which treatment…

This study tests a daily supplement called Olistic Next Women in 60 women aged 45-65 who are starting to lose hair. For 6 months, some women get the supplement and others get a placebo. Researchers will measure hair density and shedding to see if the supplement helps without caus…

This study tests whether a daily supplement called Olistic Next Women can improve hair growth and reduce hair loss in women aged 50-65 who are starting to experience female pattern hair loss. Over 6 months, 100 women will take either the supplement or a placebo, and researchers w…

This study tests whether a daily 300 mg capsule of KSM-66 Ashwagandha, an herbal supplement, can improve skin and hair health in 50 healthy adults over 12 weeks. Participants are randomly assigned to receive either the supplement or a placebo, and neither they nor the researchers…

This study aims to understand why hair follicles stop working in male pattern baldness. Researchers will collect scalp samples from 12 men (younger and older) with and without hair loss. Using advanced technology, they will map cells and genes to find key targets for future treat…

This study will measure a protein called JAK2 in the scalps of 25 people with male pattern baldness. Researchers will compare JAK2 levels in balding and non-balding areas, then see if 12 weeks of topical minoxidil 5% changes JAK2 in the balding scalp. The goal is to understand wh…

This study is testing whether a cream made from a person's own hair follicles can reduce redness, swelling, and downtime after medical aesthetic procedures like laser treatments or facelifts. Researchers will follow 500 adults aged 18 to 60 who are planning such a procedure. The …